• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
XDJ

S&P/ASX 200 Consumer Discretionary - Announcements

1.09% ! 4,054.5
Add to My Watchlist

Announcements



Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search

No announcements returned.

refresh Created with Sketch. REFRESH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4,054.5 		Change
-44.500(1.09%) 		Mkt cap ! n/a
Open High Low
4,099.0 4,099.0 4,041.6
XDJ (ASX) Chart

Top Stories

'Enough competition': ACCC nod for IAG's $855M alliance with RACQ Insurance

It’s green lights for Insurance Australia Group (ASX:IAG) and its $855 million, 25-year alliance with RACQ Insurance, with the Australian Competition and Consumer Commission today declaring it wouldn’t oppose the takeover.Listen to the HotCopper podcast for in-dept...
Lincoln proves battery-grade standard for Kookaburra graphite Lincoln Minerals Ltd has unveiled the results of purification work on graphite samples from its Kookaburra project
Raiden snaps up 75% of Vuzel gold project in Bulgaria as lithium days put to rest Raiden Resources (ASX:RDN) has all but formally pivoted away from lithium with its move to 75% ownership of the Vuzel gold...
An RBA cut was locked in. Beijing’s identical Tuesday cut spotlights larger macro forces An RBA cut was basically guaranteed. But Beijing’s identical Tuesday move spotlights larger macro forces After seeing countries...
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.In the background, Paradigm also has a rare disease clinal asset for Mucopolysaccharidosis (MPS) and early-stage data for acute respiratory d...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.